Who owns PYXIS ONCOLOGY INC?
- Ticker: PYXS
- CUSIP Number: 747324101
Tip: Access positions for across all investors
Analyze quarterly positions in Pyxis Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pyxis Oncology stock
Who bought or sold PYXIS ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pfizer | 7.0M | $20M | 0% | Jun 2026 |
|
| Laurion Capital Management | 4.9M | $15M | -2% | Jun 2026 |
|
| Vanguard Capital Management | 2.1M | $6.2M | 2% | Jun 2026 |
|
| HealthInvest Partners AB | 967k | $2.9M | 390% | Jun 2026 |
|
| BlackRock | 868k | $2.6M | 10% | Jun 2026 |
|
| Palo Alto Investors | 864k | $2.6M | -14% | Jun 2026 |
|
| Marshall Wace | 831k | $2.5M | 134% | Jun 2026 |
|
| Renaissance Technologies | 772k | $2.3M | -13% | Jun 2026 |
|
| Geode Capital Management | 592k | $1.8M | -1% | Jun 2026 |
|
| Woodline Partners | 524k | $1.6M | 100% | Jun 2026 |
|
| 683 Capital Management | 459k | $1.4M | -49% | Jun 2026 |
|
| Jacobs Levy Equity Management | 429k | $1.3M | -7% | Jun 2026 |
|
| Diadema Partners | 388k | $1.2M | 100% | Jun 2026 |
|
| Jane Street | 364k | $1.1M | 10% | Jun 2026 |
|
| Longaeva Partners | 354k | $1.1M | -30% | Jun 2026 |
|
| Decheng Capital | 327k | $984k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 303k | $912k | 1% | Jun 2026 |
|
| State Street Corporation | 249k | $363k | 3% | Mar 2026 |
|
| Millennium Management | 233k | $701k | -41% | Jun 2026 |
|
| UBS Group | 155k | $467k | -39% | Jun 2026 |
|
| Bank of New York Mellon | 134k | $403k | 0% | Jun 2026 |
|
| Acadian Asset Management | 127k | $380k | -12% | Jun 2026 |
|
| Northern Trust | 124k | $373k | 22% | Jun 2026 |
|
| NewEdge Wealth | 116k | $349k | 0% | Jun 2026 |
|
| XTX Topco | 111k | $334k | -45% | Jun 2026 |
|
| Two Sigma Investments | 84k | $253k | 15% | Jun 2026 |
|
| Bridgeway Capital Management | 81k | $245k | 0% | Jun 2026 |
|
| Bank of America Corporation | 81k | $242k | 379% | Jun 2026 |
|
| Stifel Financial | 70k | $212k | 39% | Jun 2026 |
|
| Morgan Stanley | 70k | $102k | -22% | Mar 2026 |
|
| Susquehanna International | 65k | $196k | -22% | Jun 2026 |
|
| Citadel Advisors | 62k | $187k | -52% | Jun 2026 |
|
| Cable Car Capital | 62k | $185k | 0% | Jun 2026 |
|
| MYDA Advisors | 50k | $151k | 100% | Jun 2026 |
|
| Qube Research & Technologies | 50k | $150k | 342% | Jun 2026 |
|
| University Of Chicago | 49k | $147k | 0% | Jun 2026 |
|
| Quadrature Capital | 47k | $142k | 100% | Jun 2026 |
|
| Goldman Sachs Group | 46k | $138k | -2% | Jun 2026 |
|
| Verdad Advisers | 45k | $135k | 100% | Jun 2026 |
|
| LPL Financial | 44k | $131k | 30% | Jun 2026 |
|
| Commonwealth Equity Services | 43k | $128k | 22% | Jun 2026 |
|
| J. Derek Lewis & Associates | 42k | $126k | -2% | Jun 2026 |
|
| Simplex Trading | 38k | $114k | 14881% | Jun 2026 |
|
| Point72 Asset Management | 37k | $112k | 16% | Jun 2026 |
|
| Walleye Trading Advisors | 37k | $111k | 100% | Jun 2026 |
|
| Dimensional Fund Advisors | 36k | $109k | 40% | Jun 2026 |
|
| Mackenzie Financial | 26k | $79k | 100% | Jun 2026 |
|
| Cetera Investment Advisers | 25k | $75k | -8% | Jun 2026 |
|
| Graham Capital Management | 23k | $68k | 0% | Jun 2026 |
|
| Vanguard Global Advisers | 21k | $64k | 0% | Jun 2026 |
|
| Advisor Group Holdings | 18k | $53k | 29% | Jun 2026 |
|
| Group One Trading | 17k | $50k | 100% | Jun 2026 |
|
| FMR | 12k | $37k | 4% | Jun 2026 |
|
| Paces Ferry Wealth Advisors | 11k | $34k | 0% | Jun 2026 |
|
| Goss Wealth Management | 10k | $31k | 0% | Jun 2026 |
|
| China Universal Asset Management | 10k | $30k | -9% | Jun 2026 |
|
| Tower Research Capital | 9.4k | $28k | -9% | Jun 2026 |
|
| Mercer Global Advisors | 9.2k | $28k | 100% | Jun 2026 |
|
| Pnc Financial Services | 6.5k | $20k | 0% | Jun 2026 |
|
| Winthrop Capital Management | 6.0k | $18k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 5.5k | $16k | 100% | Jun 2026 |
|
| Hager Investment Management Services | 5.0k | $15k | 0% | Jun 2026 |
|
| Barclays | 4.7k | $14k | -91% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 4.5k | $14k | 100% | Jun 2026 |
|
| Mirae Asset Global Investments | 3.2k | $4.7k | 7% | Mar 2026 |
|
| Federated Investors | 3.0k | $8.9k | -7% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 2.7k | $8.1k | 63% | Jun 2026 |
|
| First United Bank & Trust | 2.5k | $7.4k | 100% | Jun 2026 |
|
| Citigroup | 1.7k | $2.5k | 100% | Mar 2026 |
|
| Gf Fund Management | 1.2k | $3.7k | -7% | Jun 2026 |
|
| Persistent Asset Partners | 990.00 | $74k | 100% | Jun 2026 |
|
| NISA Investment Advisors | 961.00 | $2.9k | 0% | Jun 2026 |
|
| UMA Financial Services | 943.00 | $2.8k | 0% | Jun 2026 |
|
| SBI Securities | 509.00 | $1.5k | 50800% | Jun 2026 |
|
| Jones Financial Companies, L.L | 500.00 | $1.4k | 0% | Jun 2026 |
|
| Wells Fargo & Company | 285.00 | $857.992500 | 0% | Jun 2026 |
|
| Cornerstone Financial Management | 172.00 | $517.995200 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 35.00 | $105.000000 | 775% | Jun 2026 |
|
| CWM | 34.00 | $50.000400 | -51% | Mar 2026 |
|
| SRS Capital Advisors | 14.00 | $42.000000 | 1300% | Jun 2026 |
|
Who sold out of Pyxis Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| PanAgora Asset Management | Mar 2026 | 69k | $101k |
| Toronto-Dominion Bank | Mar 2026 | 50k | $73k |
| Maia Wealth | Mar 2026 | 21k | $31k |
| Catalyst Funds Management Pty | Mar 2026 | 20k | $30k |
| Squarepoint Ops | Mar 2026 | 18k | $26k |
| Two Sigma Securities | Mar 2026 | 14k | $20k |
| Royal Bank of Canada | Mar 2026 | 5.8k | $9.0k |
| Balyasny Asset Management | Mar 2026 | 743.00 | $1.1k |
| Us Bancorp | Dec 2025 | 94.00 | $107.996600 |